Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.6 USD | +8.49% | +15.14% | +24.44% |
05-09 | NeuroBo Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-08 | Maxim Initiates NeuroBo Pharmaceuticals With Buy Rating, $10 Price Target | MT |
- Stock Market
- Equities
- NRBO Stock
- News NeuroBo Pharmaceuticals, Inc.
- MarketScreener Strategies